The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shannon Colin since 2006.
This trader's CIK number is 1285101.
At the time of last reporting, Shannon Colin was the President & CEO of Pra Health Sciences, Inc.. (stock ticker symbol PRAH).
Also see all insider trading activities at Pra Health Sciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | PRAH | 0 | $0 | 231,348 | $38,850,571 | 221,031 | $2,592,692 |
| 2020 | PRAH | 0 | $0 | 6,073 | $624,790 | 0 | $0 |
| 2017 | PRAH | 0 | $0 | 550,000 | $39,289,998 | 550,000 | $3,374,999 |
| 2016 | PRAH | 0 | $0 | 190,152 | $9,088,623 | 202,382 | $595,003 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | PPDI | 0 | $0 | 42,167 | $1,449,458 | 42,167 | $837,836 |
| 2006 | PPDI | 0 | $0 | 71,167 | $2,519,311 | 71,167 | $1,209,625 |
1. Pra Health Sciences, Inc. (PRAH)
2. Pharmaceutical Product Development Inc (PPDI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-16 | PRAH | Option Ex | 88,045 | 11.73 | 1,032,767 |
| 2021-06-15 | PRAH | Sale | 143,303 | 168.53 | 24,150,138 |
| 2021-06-16 | PRAH | Sale | 88,045 | 166.97 | 14,700,433 |
| 2021-06-15 | PRAH | Option Ex | 132,986 | 11.73 | 1,559,925 |
| 2020-08-13 | PRAH | Sale | 6,073 | 102.88 | 624,790 |
| 2017-08-14 | PRAH | Sale | 400,000 | 74.85 | 29,939,999 |
| 2017-08-08 | PRAH | Option Ex | 400,000 | 7.33 | 2,934,000 |
| 2017-03-28 | PRAH | Option Ex | 50,000 | 2.94 | 147,000 |
| 2017-03-28 | PRAH | Sale | 50,000 | 64.00 | 3,200,000 |
| 2017-02-21 | PRAH | Sale | 2,747 | 61.50 | 168,940 |
| 2017-02-23 | PRAH | Option Ex | 97,253 | 2.94 | 285,923 |
| 2017-02-23 | PRAH | Sale | 97,253 | 61.50 | 5,981,059 |
| 2017-02-21 | PRAH | Option Ex | 2,747 | 2.94 | 8,076 |
| 2016-08-18 | PRAH | Option Ex | 120,000 | 2.94 | 352,800 |
| 2016-08-18 | PRAH | Sale | 10,822 | 51.76 | 560,146 |
| 2016-08-19 | PRAH | Sale | 19,694 | 51.40 | 1,012,271 |
| 2016-08-22 | PRAH | Sale | 82,617 | 51.58 | 4,261,384 |
| 2016-03-08 | PRAH | Sale | 77,019 | 42.26 | 3,254,822 |
| 2016-03-02 | PRAH | Option Ex | 82,382 | 2.94 | 242,203 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-05-04 | PPDI | Sale | 9,667 | 35.15 | 339,746 |
| 2007-05-04 | PPDI | Option Ex | 9,667 | 15.43 | 149,161 |
| 2007-02-09 | PPDI | Sale | 32,500 | 34.15 | 1,109,712 |
| 2007-02-09 | PPDI | Option Ex | 32,500 | 21.19 | 688,675 |
| 2006-10-20 | PPDI | Sale | 71,167 | 35.40 | 2,519,311 |
| 2006-10-20 | PPDI | Option Ex | 71,167 | 17.00 | 1,209,625 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shannon Colin (President & CEO of Pra Health Sciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.